On June 3, 2024, Medtronic, Inc., a wholly-owned indirect subsidiary of Medtronic plc, the leading global healthcare technology company, announced the closing of its recent public offering of €850 million aggregate principal amount of 3.650% Senior Notes due 2029, €850 million aggregate principal amount of 3.875% Senior Notes due 2036, €600 million aggregate principal amount of 4.150% Senior Notes due 2043 and €700 million aggregate principal amount of 4.150% Senior Notes due 2053. Medtronic expects to use net proceeds from the offering for general corporate purposes, which may include the repayment of outstanding commercial paper and other indebtedness.
The WilmerHale team advising Medtronic was led by Justin Ochs and Craig Hilts, and included Andrew Langworthy, Sarah Matchett and Emily Ivers, with assistance from Julie Hogan Rodgers and Ben Kelsey (Tax), Timothy Silva and Ben Lobley (Investment Management) and Heidi Treiber (Corporate).